Côte d'Ivoire vs Côte d'Ivoire: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Côte d'Ivoire
0.6%
in 2024
Côte d'Ivoire
0.6%
in 2024
Côte d'Ivoire rank
60th
Côte d'Ivoire rank
60th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Côte d'Ivoire
- Côte d'Ivoire
How they compare
Côte d'Ivoire currently reports 0.6% against 0.6% in Côte d'Ivoire, a difference of 0.0%.
Across all 10 years both countries report, Côte d'Ivoire has been ahead every year.
Côte d'Ivoire ranks 60th and Côte d'Ivoire ranks 60th of 246 countries.
Head to head by decade
| Decade | Côte d'Ivoire | Côte d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.2% | 1.2% | 0.0% | — |
| 2020s | 0.7% | 0.7% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Côte d'Ivoire or Côte d'Ivoire?
- Côte d'Ivoire, at 0.6% against 0.6% in Côte d'Ivoire as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Côte d'Ivoire and Côte d'Ivoire?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Côte d'Ivoire?
- 10 years are reported by both, from 2015 to 2024.
- How do Côte d'Ivoire and Côte d'Ivoire rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Côte d'Ivoire ranks 60th and Côte d'Ivoire ranks 60th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.